MANAGEMENT OF STAGE-I MALIGNANT-MELANOMA

被引:13
|
作者
GREENSTEIN, DS
ROGERS, GS
机构
[1] BOSTON UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA 02118
[2] BOSTON UNIV,SCH MED,DEPT SURG,BOSTON,MA 02118
关键词
D O I
10.1111/j.1524-4725.1995.tb00528.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Because of the rising incidence of melanoma, dermatologists are increasingly responsible for diagnosing and managing patients with this cutaneous malignancy. Fortunately, with the increased awareness and emphasis on early detection, most patients will present with tumors that have not yet spread beyond their primary focus in the skin (ie, Stage I). Dermatologists must, therefore, be fully versed in the diagnosis and management of Stage I melanoma. OBJECTIVE. This review article focuses on the most important issues related to the diagnosis and management of Stage I mel anoma. An emphasis will be placed on surgical management. RESULTS. The mainstay of therapy for most patients with Stage I melanoma is surgery. The important principles of diagnostic biopsy and surgical excision will be discussed. There are several additional modalities that may be useful as adjuvants to surgical therapy or as primary therapy in situations when surgery is not feasible. Those include elective lymph node dissection, hyperthermic isolation limb perfusion, radiotherapy, cryotherapy, chemotherapy, and immunotherapy. These will all be reviewed. CONCLUSIONS. With a thorough understanding of the important principles and controversies related to the management of Stage I melanoma, dermatologists can effectively manage the growing number of patients with this malignancy.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
  • [1] SURGICAL-MANAGEMENT OF STAGE-I MALIGNANT-MELANOMA
    ROGERS, GS
    [J]. DERMATOLOGIC CLINICS, 1991, 9 (04) : 649 - 655
  • [2] PROGNOSIS OF STAGE-I MALIGNANT-MELANOMA
    DVIR, E
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1988, 81 (06): : 988 - 988
  • [3] LATE RECURRENCE OF STAGE-I MALIGNANT-MELANOMA
    GUTMAN, M
    KLAUSNER, JM
    INBAR, M
    ROZIN, RR
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1989, 42 (02) : 96 - 98
  • [4] PROGNOSIS FOR RECURRENT STAGE-I MALIGNANT-MELANOMA
    REINTGEN, DS
    VOLLMER, R
    TSO, CY
    SEIGLER, HF
    [J]. ARCHIVES OF SURGERY, 1987, 122 (11) : 1338 - 1342
  • [5] LYMPHADENECTOMY IN THE MANAGEMENT OF STAGE-I MALIGNANT-MELANOMA - A PROSPECTIVE RANDOMIZED STUDY
    SIM, FH
    TAYLOR, WF
    PRITCHARD, DJ
    SOULE, EH
    [J]. MAYO CLINIC PROCEEDINGS, 1986, 61 (09) : 697 - 705
  • [6] NARROWER MARGINS FOR CLINICAL STAGE-I MALIGNANT-MELANOMA
    DAY, CL
    MIHM, MC
    SOBER, AJ
    FITZPATRICK, TB
    MALT, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (08): : 479 - 482
  • [7] HYPERTHERMIC PERFUSION FOR STAGE-I MALIGNANT-MELANOMA OF THE EXTREMITY
    REGE, V
    FIJMAN, R
    SODERBERG, C
    COLEMAN, G
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 189 - 189
  • [8] CHANGES IN SURVIVAL WITH CLINICAL STAGE-I MALIGNANT-MELANOMA
    KARAKOUSIS, CP
    KACHRIMANIDIS, S
    RAO, U
    EMRICH, LJ
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1987, 34 (03) : 155 - 159
  • [9] EVALUATION OF PROGNOSTIC CHARACTERISTICS OF STAGE-I CUTANEOUS MALIGNANT-MELANOMA
    TAN, GJKH
    BAAK, JPA
    [J]. ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1984, 6 (03): : 147 - 154
  • [10] CLINICAL AND LABORATORY EVALUATION OF PATIENTS WITH STAGE-I MALIGNANT-MELANOMA
    ROGERS, G
    POLLACK, SV
    KOPF, AW
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1988, 14 (01): : 100 - 101